This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,169.59 firm-fixed-price delivery order is for the supply of Xtandi 80 mg tablets, a specialty pharmaceutical product, with a completion date of September 30, 2024.
The award is part of a larger $499,999,999 indefinite-delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This IDC, which runs through December 31, 2025, is a crucial component of DMS Pharmaceutical Group's role as a prime vendor for the direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) healthcare sites.
Generated 12/27/24, 9:14 AM